Joinn Laboratories China Co Ltd
SSE:603127
Joinn Laboratories China Co Ltd
Operating Income
Joinn Laboratories China Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
Joinn Laboratories China Co Ltd
SSE:603127
|
Operating Income
¥483.4m
|
CAGR 3-Years
15%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Operating Income
¥10.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Operating Income
¥1.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Operating Income
¥4.1B
|
CAGR 3-Years
36%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Operating Income
¥1.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
25%
|
CAGR 10-Years
32%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Operating Income
¥190.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Joinn Laboratories China Co Ltd's Operating Income?
Operating Income
483.4m
CNY
Based on the financial report for Mar 31, 2024, Joinn Laboratories China Co Ltd's Operating Income amounts to 483.4m CNY.
What is Joinn Laboratories China Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
33%
Over the last year, the Operating Income growth was -34%. The average annual Operating Income growth rates for Joinn Laboratories China Co Ltd have been 15% over the past three years , 33% over the past five years .